Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.
Korean biotech firm bought by Parataxis for Bitcoin treasury use
Related posts
Western Union eyes inflation-resistant ‘stable cards’ as part of its stablecoin strategy
Bitcoin treads water at $90K as whales eat the Ethereum dip: Finance Redefined
Buy every dip? How pro hodlers blend surgical DCA with rules-based crypto buys
Solana WET presale hijacked by Sybil wallets as HumidiFi resets launch
US investors consider crypto less as risk-taking drops: FINRA study
Ether vs. Bitcoin teases 170% gains as ETH price breaks 5-month downtrend
